These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 29587436)
1. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Clemens EB; van de Sandt C; Wong SS; Wakim LM; Valkenburg SA Vaccines (Basel); 2018 Mar; 6(2):. PubMed ID: 29587436 [TBL] [Abstract][Full Text] [Related]
2. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses. Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P J Virol; 2017 May; 91(9):. PubMed ID: 28179535 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
4. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
5. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model. Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL Front Immunol; 2018; 9():116. PubMed ID: 29449842 [TBL] [Abstract][Full Text] [Related]
6. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines. Sridhar S Front Immunol; 2016; 7():195. PubMed ID: 27242800 [TBL] [Abstract][Full Text] [Related]
7. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice. Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985 [TBL] [Abstract][Full Text] [Related]
8. Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection. Kwon JS; Yoon J; Kim YJ; Kang K; Woo S; Jung DI; Song MK; Kim EH; Kwon HI; Choi YK; Kim J; Lee J; Yoon Y; Shin EC; Youn JW Eur J Immunol; 2014 Aug; 44(8):2360-9. PubMed ID: 24825439 [TBL] [Abstract][Full Text] [Related]
9. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Sarawar S; Hatta Y; Watanabe S; Dias P; Neumann G; Kawaoka Y; Bilsel P Vaccine; 2016 Sep; 34(42):5090-5098. PubMed ID: 27595896 [TBL] [Abstract][Full Text] [Related]
10. Towards a universal influenza vaccine: different approaches for one goal. Sautto GA; Kirchenbaum GA; Ross TM Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862 [TBL] [Abstract][Full Text] [Related]
12. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine. van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929 [TBL] [Abstract][Full Text] [Related]
13. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity. Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227 [TBL] [Abstract][Full Text] [Related]
14. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA Front Immunol; 2019; 10():756. PubMed ID: 31105689 [TBL] [Abstract][Full Text] [Related]
15. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Janssens Y; Joye J; Waerlop G; Clement F; Leroux-Roels G; Leroux-Roels I Front Immunol; 2022; 13():959379. PubMed ID: 36052083 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
17. The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine. Valkenburg SA; Leung NHL; Bull MB; Yan LM; Li APY; Poon LLM; Cowling BJ Front Immunol; 2018; 9():1479. PubMed ID: 30013557 [TBL] [Abstract][Full Text] [Related]
18. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice. Joe PT; Christopoulou I; van Hoecke L; Schepens B; Ysenbaert T; Heirman C; Thielemans K; Saelens X; Aerts JL J Transl Med; 2019 Jul; 17(1):242. PubMed ID: 31345237 [TBL] [Abstract][Full Text] [Related]
19. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza. Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565 [TBL] [Abstract][Full Text] [Related]
20. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine. Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]